NWS
GILD icon

Nvest Wealth Strategies’s Gilead Sciences GILD Stock Holding History

Nvest Wealth Strategies’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10
Closed -$1.39K – 386
2026
Q1 		$1.39K Buy
+10
New +$1.4K ﹤0.01% 200

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Nvest Wealth Strategies's GILD Position: Q2 2026 in Review

Nvest Wealth Strategies sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 10 shares — an estimated $1.39K sold.

Nvest Wealth Strategies first reported a position in GILD in Q1 2026 and held it in 1 quarter. The position peaked at $1.39K in Q1 2026. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Nvest Wealth Strategies reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Nvest Wealth Strategies sold 10 Gilead Sciences shares in Q2 2026, an estimated $1.39K.
  • Nvest Wealth Strategies first reported a position in Gilead Sciences in Q1 2026 and held it in 1 quarter.
  • Nvest Wealth Strategies's Gilead Sciences position peaked at $1.39K in Q1 2026.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Nvest Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.